{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T14:14:05Z","timestamp":1791382445775,"version":"4.3.3"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T00:00:00Z","timestamp":1739491200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005010","name":"Italian Association for Cancer Research","doi-asserted-by":"publisher","award":["IG2019-23069"],"award-info":[{"award-number":["IG2019-23069"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.biopha.2025.117917","type":"journal-article","created":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T18:02:46Z","timestamp":1739815366000},"page":"117917","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Mitotane activates ATF4\/ATF3 axis triggering endoplasmic reticulum stress in adrenocortical carcinoma cells"],"prefix":"10.1016","volume":"184","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-9796-3106","authenticated-orcid":false,"given":"Aurora","family":"Schiavon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Saba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlotta","family":"Evaristo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8640-2462","authenticated-orcid":false,"given":"Jessica","family":"Petiti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ymera","family":"Pignochino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4580-0680","authenticated-orcid":false,"given":"Giulio","family":"Ferrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgia","family":"Giordano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Tucciarello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2883-6139","authenticated-orcid":false,"given":"Soraya","family":"Puglisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9489-2094","authenticated-orcid":false,"given":"Giuseppe","family":"Reimondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Terzolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Lo Iacono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.biopha.2025.117917_bib1","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1016\/j.annonc.2020.08.2099","article-title":"E.G.C.E.a. clinicalguidelines@esmo.org, Adrenocortical carcinomas and malignant phaeochromocytomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"31","author":"Fassnacht","year":"2020","journal-title":"Ann. Oncol."},{"issue":"5","key":"10.1016\/j.biopha.2025.117917_bib2","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1210\/clinem\/dgac046","article-title":"Temporal trends in outcomes in patients with adrenocortical carcinoma: a multidisciplinary referral-center experience","volume":"107","author":"Daher","year":"2022","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.biopha.2025.117917_bib3","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/cncr.24030","article-title":"T. European Network for the Study of Adrenal, Limited prognostic value of the 2004 International Union Against Cancer staging classification for adrenocortical carcinoma: proposal for a Revised TNM Classification","volume":"115","author":"Fassnacht","year":"2009","journal-title":"Cancer"},{"issue":"10","key":"10.1016\/j.biopha.2025.117917_bib4","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1210\/clinem\/dgad199","article-title":"New findings on presentation and outcome of patients with adrenocortical cancer: results from a National Cohort Study","volume":"108","author":"Puglisi","year":"2023","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.biopha.2025.117917_bib5","article-title":"Adrenocortical carcinoma: diagnosis, prognostic classification and treatment of localized and advanced disease","volume":"37","author":"Libe","year":"2023","journal-title":"Cancer Treat. Res Commun."},{"issue":"2","key":"10.1016\/j.biopha.2025.117917_bib6","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.ecl.2018.02.003","article-title":"Adrenocortical carcinoma with hypercortisolism","volume":"47","author":"Puglisi","year":"2018","journal-title":"Endocrinol. Metab. Clin. North Am."},{"issue":"1","key":"10.1016\/j.biopha.2025.117917_bib7","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.surg.2023.04.070","article-title":"The effect of hormonal secretion on survival in adrenocortical carcinoma: a multi-center study","volume":"175","author":"Sada","year":"2024","journal-title":"Surgery"},{"issue":"6","key":"10.1016\/j.biopha.2025.117917_bib8","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.amjsurg.2015.09.020","article-title":"Outcomes after resection of cortisol-secreting adrenocortical carcinoma","volume":"211","author":"Margonis","year":"2016","journal-title":"Am. J. Surg."},{"issue":"7","key":"10.1016\/j.biopha.2025.117917_bib9","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.1210\/jc.2005-2730","article-title":"Clinical and biological features in the prognosis of adrenocortical cancer: poor outcome of cortisol-secreting tumors in a series of 202 consecutive patients","volume":"91","author":"Abiven","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"9","key":"10.1016\/j.biopha.2025.117917_bib10","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/s41574-019-0221-7","article-title":"Adrenocortical carcinoma - towards genomics guided clinical care","volume":"15","author":"Crona","year":"2019","journal-title":"Nat. Rev. Endocrinol."},{"issue":"6","key":"10.1016\/j.biopha.2025.117917_bib11","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/ng.2953","article-title":"Integrated genomic characterization of adrenocortical carcinoma","volume":"46","author":"Assie","year":"2014","journal-title":"Nat. Genet"},{"issue":"2","key":"10.1016\/j.biopha.2025.117917_bib12","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.ccell.2016.07.013","article-title":"Comprehensive pan-genomic characterization of adrenocortical carcinoma","volume":"30","author":"Zheng","year":"2016","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.biopha.2025.117917_bib13","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.surg.2018.04.068","article-title":"Longitudinal patterns of recurrence in patients with adrenocortical carcinoma","volume":"165","author":"Glenn","year":"2019","journal-title":"Surgery"},{"issue":"1","key":"10.1016\/j.biopha.2025.117917_bib14","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1210\/jc.2012-2559","article-title":"G. German Adrenocortical Carcinoma Study, The role of surgery in the management of recurrent adrenocortical carcinoma","volume":"98","author":"Erdogan","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.biopha.2025.117917_bib15","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1245\/s10434-015-4810-y","article-title":"Curative Resection of Adrenocortical Carcinoma: Rates and Patterns of Postoperative Recurrence","volume":"23","author":"Amini","year":"2016","journal-title":"Ann. Surg. Oncol."},{"issue":"3","key":"10.1016\/j.biopha.2025.117917_bib16","doi-asserted-by":"crossref","first-page":"R27","DOI":"10.1530\/EJE-22-0260","article-title":"ENDOCRINE TUMOURS: our experience with the management of patients with non-metastatic adrenocortical carcinoma","volume":"187","author":"Terzolo","year":"2022","journal-title":"Eur. J. Endocrinol."},{"issue":"23","key":"10.1016\/j.biopha.2025.117917_bib17","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1056\/NEJMoa1200966","article-title":"F.-A.S. Group, Combination chemotherapy in advanced adrenocortical carcinoma","volume":"366","author":"Fassnacht","year":"2012","journal-title":"N. Engl. J. Med"},{"issue":"4","key":"10.1016\/j.biopha.2025.117917_bib18","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1210\/jc.2017-02591","article-title":"A.C.C.S.G. German, Mitotane monotherapy in patients with advanced adrenocortical carcinoma","volume":"103","author":"Megerle","year":"2018","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.biopha.2025.117917_bib19","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/9362108","article-title":"Benefits of adjuvant mitotane after resection of adrenocortical carcinoma: a systematic review and meta-analysis","volume":"2018","author":"Tang","year":"2018","journal-title":"Biomed. Res Int"},{"issue":"1","key":"10.1016\/j.biopha.2025.117917_bib20","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1210\/jc.2012-2851","article-title":"Mitotane therapy in adrenocortical cancer induces CYP3A4 and inhibits 5alpha-reductase, explaining the need for personalized glucocorticoid and androgen replacement","volume":"98","author":"Chortis","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.biopha.2025.117917_bib21","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s13318-021-00700-5","article-title":"The challenging pharmacokinetics of mitotane: an old drug in need of new packaging","volume":"46","author":"Haider","year":"2021","journal-title":"Eur. J. Drug Metab. Pharm."},{"issue":"6","key":"10.1016\/j.biopha.2025.117917_bib22","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/0022-4731(73)90033-2","article-title":"Complexing of DDT and o,p'DDD with adrenal cytochrome P-450 hydroxylating systems","volume":"4","author":"Young","year":"1973","journal-title":"J. Steroid Biochem"},{"issue":"21","key":"10.1016\/j.biopha.2025.117917_bib23","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13215255","article-title":"Molecular mechanisms of mitotane action in adrenocortical cancer based on in vitro studies","volume":"13","author":"Lo Iacono","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"7","key":"10.1016\/j.biopha.2025.117917_bib24","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1111\/bcp.14721","article-title":"Pharmacological profile and effects of mitotane in adrenocortical carcinoma","volume":"87","author":"Corso","year":"2021","journal-title":"Br. J. Clin. Pharm."},{"issue":"11","key":"10.1016\/j.biopha.2025.117917_bib25","doi-asserted-by":"crossref","first-page":"3895","DOI":"10.1210\/en.2015-1367","article-title":"Mitotane Inhibits Sterol-O-Acyl Transferase 1 Triggering Lipid-Mediated Endoplasmic Reticulum Stress and Apoptosis in Adrenocortical Carcinoma Cells","volume":"156","author":"Sbiera","year":"2015","journal-title":"Endocrinology"},{"issue":"66","key":"10.1016\/j.biopha.2025.117917_bib26","doi-asserted-by":"crossref","first-page":"109924","DOI":"10.18632\/oncotarget.18968","article-title":"Identifying mitotane-induced mitochondria-associated membranes dysfunctions: metabolomic and lipidomic approaches","volume":"8","author":"Hescot","year":"2017","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.biopha.2025.117917_bib27","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1530\/ERC-12-0368","article-title":"Mitotane alters mitochondrial respiratory chain activity by inducing cytochrome c oxidase defect in human adrenocortical cells","volume":"20","author":"Hescot","year":"2013","journal-title":"Endocr. Relat. Cancer"},{"issue":"23","key":"10.1016\/j.biopha.2025.117917_bib28","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242316701","article-title":"Albumin\/mitotane interaction affects drug activity in adrenocortical carcinoma cells: smoke and mirrors on mitotane effect with possible implications for patients' management","volume":"24","author":"Schiavon","year":"2023","journal-title":"Int J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.biopha.2025.117917_bib29","doi-asserted-by":"crossref","first-page":"2890","DOI":"10.1210\/JC.2015-2080","article-title":"Lipoprotein-free mitotane exerts high cytotoxic activity in adrenocortical carcinoma","volume":"100","author":"Hescot","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"17","key":"10.1016\/j.biopha.2025.117917_bib30","doi-asserted-by":"crossref","first-page":"i884","DOI":"10.1093\/bioinformatics\/bty560","article-title":"fastp: an ultra-fast all-in-one FASTQ preprocessor","volume":"34","author":"Chen","year":"2018","journal-title":"Bioinformatics"},{"issue":"4","key":"10.1016\/j.biopha.2025.117917_bib31","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nmeth.4197","article-title":"Salmon provides fast and bias-aware quantification of transcript expression","volume":"14","author":"Patro","year":"2017","journal-title":"Nat. Methods"},{"issue":"1","key":"10.1016\/j.biopha.2025.117917_bib32","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","article-title":"edgeR: a Bioconductor package for differential expression analysis of digital gene expression data","volume":"26","author":"Robinson","year":"2010","journal-title":"Bioinformatics"},{"issue":"7","key":"10.1016\/j.biopha.2025.117917_bib33","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkv007","article-title":"limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"10.1016\/j.biopha.2025.117917_bib34","doi-asserted-by":"crossref","DOI":"10.1186\/gb-2010-11-2-r14","article-title":"Gene ontology analysis for RNA-seq: accounting for selection bias","volume":"11","author":"Young","year":"2010","journal-title":"Genome Biol."},{"issue":"17","key":"10.1016\/j.biopha.2025.117917_bib35","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1093\/bioinformatics\/btq401","article-title":"ROAST: rotation gene set tests for complex microarray experiments","volume":"26","author":"Wu","year":"2010","journal-title":"Bioinformatics"},{"issue":"14","key":"10.1016\/j.biopha.2025.117917_bib36","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1093\/bioinformatics\/btt285","article-title":"Pathview: an R\/Bioconductor package for pathway-based data integration and visualization","volume":"29","author":"Luo","year":"2013","journal-title":"Bioinformatics"},{"issue":"1","key":"10.1016\/j.biopha.2025.117917_bib37","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1186\/s12859-016-1181-8","article-title":"Interpreting transcriptional changes using causal graphs: new methods and their practical utility on public networks","volume":"17","author":"Fakhry","year":"2016","journal-title":"BMC Bioinforma."},{"issue":"3","key":"10.1016\/j.biopha.2025.117917_bib38","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1128\/MCB.24.3.1365-1377.2004","article-title":"Activating transcription factor 3 is integral to the eukaryotic initiation factor 2 kinase stress response","volume":"24","author":"Jiang","year":"2004","journal-title":"Mol. Cell Biol."},{"issue":"10","key":"10.1016\/j.biopha.2025.117917_bib39","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1038\/sj.onc.1207991","article-title":"Identification of ATF-3, caveolin-1, DLC-1, and NM23-H2 as putative antitumorigenic, progesterone-regulated genes for ovarian cancer cells by gene profiling","volume":"24","author":"Syed","year":"2005","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.biopha.2025.117917_bib40","doi-asserted-by":"crossref","first-page":"466","DOI":"10.4049\/jimmunol.182.1.466","article-title":"CHAC1\/MGC4504 is a novel proapoptotic component of the unfolded protein response, downstream of the ATF4-ATF3-CHOP cascade","volume":"182","author":"Mungrue","year":"2009","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2025.117917_bib41","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/s13046-017-0648-4","article-title":"PSAT1 is regulated by ATF4 and enhances cell proliferation via the GSK3beta\/beta-catenin\/cyclin D1 signaling pathway in ER-negative breast cancer","volume":"36","author":"Gao","year":"2017","journal-title":"J. Exp. Clin. Cancer Res"},{"issue":"5","key":"10.1016\/j.biopha.2025.117917_bib42","doi-asserted-by":"crossref","DOI":"10.3892\/or.2021.8191","article-title":"Dihydroartemisinin triggers ferroptosis in primary liver cancer cells by promoting and unfolded protein response\u2011induced upregulation of CHAC1 expression","volume":"46","author":"Wang","year":"2021","journal-title":"Oncol. Rep."},{"issue":"70","key":"10.1016\/j.biopha.2025.117917_bib43","doi-asserted-by":"crossref","first-page":"114588","DOI":"10.18632\/oncotarget.23055","article-title":"CHAC1 degradation of glutathione enhances cystine-starvation-induced necroptosis and ferroptosis in human triple negative breast cancer cells via the GCN2-eIF2alpha-ATF4 pathway","volume":"8","author":"Chen","year":"2017","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.biopha.2025.117917_bib44","first-page":"13","article-title":"Understanding mitotane mode of action","volume":"68","author":"Waszut","year":"2017","journal-title":"J. Physiol. Pharm."},{"issue":"2","key":"10.1016\/j.biopha.2025.117917_bib45","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1530\/EC-19-0510","article-title":"Generation and characterization of a mitotane-resistant adrenocortical cell line","volume":"9","author":"Seidel","year":"2020","journal-title":"Endocr. Connect"},{"issue":"1-3","key":"10.1016\/j.biopha.2025.117917_bib46","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.tox.2012.04.007","article-title":"Mitotane exhibits dual effects on steroidogenic enzymes gene transcription under basal and cAMP-stimulating microenvironments in NCI-H295 cells","volume":"298","author":"Lin","year":"2012","journal-title":"Toxicology"},{"issue":"5","key":"10.1016\/j.biopha.2025.117917_bib47","article-title":"CYP11B1 has no role in mitotane action and metabolism in adrenocortical carcinoma cells","volume":"13","author":"Germano","year":"2018","journal-title":"PLoS ONE [Electron. Resour. ]"},{"issue":"5","key":"10.1016\/j.biopha.2025.117917_bib48","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1007\/s12672-014-0189-7","article-title":"The lack of antitumor effects of o,p'DDA excludes its role as an active metabolite of mitotane for adrenocortical carcinoma treatment","volume":"5","author":"Hescot","year":"2014","journal-title":"Horm. Cancer"},{"issue":"3","key":"10.1016\/j.biopha.2025.117917_bib49","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1530\/JOE-13-0210","article-title":"Mitotane reduces human and mouse ACTH-secreting pituitary cell viability and function","volume":"218","author":"Gentilin","year":"2013","journal-title":"J. Endocrinol."},{"issue":"1","key":"10.1016\/j.biopha.2025.117917_bib50","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12010247","article-title":"Sterol O-Acyl Transferase 1 as a Prognostic Marker of Adrenocortical Carcinoma","volume":"12","author":"Lacombe","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"2","key":"10.1016\/j.biopha.2025.117917_bib51","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgz001","article-title":"The efficacy of mitotane in human primary adrenocortical carcinoma cultures","volume":"105","author":"van Koetsveld","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"8","key":"10.1016\/j.biopha.2025.117917_bib52","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgaa293","article-title":"Expression of SOAT1 in adrenocortical carcinoma and response to mitotane monotherapy: an ENSAT multicenter study","volume":"105","author":"Weigand","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.biopha.2025.117917_bib53","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1007\/s00204-024-03681-x","article-title":"ATF4 in cellular stress, ferroptosis, and cancer","volume":"98","author":"Tang","year":"2024","journal-title":"Arch. Toxicol."},{"issue":"44","key":"10.1016\/j.biopha.2025.117917_bib54","doi-asserted-by":"crossref","first-page":"22269","DOI":"10.1073\/pnas.1912700116","article-title":"Exquisite sensitivity of adrenocortical carcinomas to induction of ferroptosis","volume":"116","author":"Belavgeni","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"3","key":"10.1016\/j.biopha.2025.117917_bib55","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/s41419-020-2385-4","article-title":"Active steroid hormone synthesis renders adrenocortical cells highly susceptible to type II ferroptosis induction","volume":"11","author":"Weigand","year":"2020","journal-title":"Cell Death Dis."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225001118?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225001118?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T23:21:17Z","timestamp":1778541677000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332225001118"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":55,"alternative-id":["S0753332225001118"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2025.117917","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mitotane activates ATF4\/ATF3 axis triggering endoplasmic reticulum stress in adrenocortical carcinoma cells","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2025.117917","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"117917"}}